News Headlines Article

Members of FDA panel call for withdrawal of Meridia diet drug
Los Angeles Times

In a rebuke of the Abbott Laboratories diet drug Meridia, eight of 16 members of a Food and Drug Administration advisory panel said Wednesday that the drug should be withdrawn from the U.S. market.

Six of the panelists said the drug should be prescribed only by “specially trained physicians.” The other two panelists said a new black box warning should be added to alert doctors to the increased risks of heart attacks and the need for closer monitoring of patients’ blood pressure, pulse and body weight.